Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...
Experts participating in the Blood and Beyond initiative call on EU and national policymakers to recognise the importance of ...
Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk chronic lymphocytic leukemia (CLL), ...
STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the ...
An update from Karolinska Development AB ( ($SE:KDEV) ) is now available. Karolinska Development’s portfolio company, Modus Therapeutics, has ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...
Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...
Scott Adams, creator of Dilbert, pleaded with President Donald Trump for help after his cancer diagnosis, Kennedy responded.
The Morning Journal on MSN
Vitalant urging blood donors to visit upcoming Lorain County drives
Every two seconds, a patient in the U.S. needs blood, but fewer donors give as end-of-year holiday activities start to fill calendars, according to a news release. That’s why nonprofit Vitalant, ...
Zocilurtatug pelitecan shows promising results as a DLL3-targeted therapy for small cell lung cancer, with high response rates and ongoing trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback